Chia-Hung Chen Selected Research

Communicable Diseases (Infectious Diseases)

11/2020	Microfluidic compartmentalization to identify gene biomarkers of infection.
1/2012	Secondary spontaneous pneumothorax: which associated conditions benefit from pigtail catheter treatment?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chia-Hung Chen Research Topics

Disease

32	Neoplasms (Cancer) 08/2023 - 11/2010
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2018
10	Lung Neoplasms (Lung Cancer) 01/2023 - 05/2014
10	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2014
10	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2013
8	Neoplasm Metastasis (Metastasis) 04/2024 - 04/2015
8	Infections 06/2023 - 08/2007
6	Pneumonia (Pneumonitis) 07/2023 - 03/2010
6	Asthma (Bronchial Asthma) 01/2021 - 01/2015
3	Wounds and Injuries (Trauma) 11/2022 - 10/2010
3	Triple Negative Breast Neoplasms 01/2020 - 11/2013
3	Disease Progression 01/2019 - 04/2015
3	Oncogene Addiction 01/2018 - 11/2013
3	Pleural Effusion (Pleural Effusions) 01/2018 - 02/2009
2	Inflammation (Inflammations) 06/2023 - 12/2019
2	Hemorrhage 01/2023 - 10/2010
2	Melanoma (Melanoma, Malignant) 01/2023 - 04/2020
2	Bacterial Infections (Bacterial Infection) 11/2022 - 01/2017
2	Brain Neoplasms (Brain Tumor) 01/2022 - 09/2020
2	Healthcare-Associated Pneumonia 01/2022 - 01/2021
2	Ventilator-Associated Pneumonia 01/2022 - 01/2021
2	Pathologic Constriction (Stenosis) 01/2021 - 09/2019
2	Shock 01/2021 - 04/2019
2	Communicable Diseases (Infectious Diseases) 11/2020 - 01/2012
2	Leukemia 11/2019 - 07/2016
2	Critical Illness (Critically Ill) 04/2019 - 02/2009
2	Acute Kidney Injury (Acute Renal Failure) 04/2019 - 04/2008
2	Respiratory Insufficiency (Respiratory Failure) 04/2019 - 04/2008
2	Endometriosis 05/2013 - 02/2013
2	End Stage Liver Disease 07/2012 - 03/2011
2	Abscess 02/2012 - 06/2005
2	Fever (Fevers) 02/2012 - 06/2005
2	Pneumothorax 01/2012 - 11/2006
2	Empyema 09/2009 - 08/2007
1	Paronychia 02/2024
1	Diarrhea 02/2024
1	Nasopharyngeal Carcinoma 12/2023
1	Adenocarcinoma 09/2023
1	Hepatitis 01/2023
1	Cartilage Diseases (Cartilage Disease) 11/2022

Drug/Important Bio-Agent (IBA)

16	Tyrosine Kinase InhibitorsIBA 04/2024 - 01/2013
13	ErbB Receptors (EGF Receptor)IBA 04/2024 - 11/2013
9	Proteins (Proteins, Gene)FDA Link 08/2023 - 11/2010
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 06/2005
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 09/2014
5	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 02/2013
4	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 07/2023 - 01/2021
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 11/2010
4	SmokeIBA 12/2019 - 01/2014
3	AfatinibIBA 02/2024 - 05/2018
3	Sulbactam FDA LinkGeneric 07/2023 - 01/2021
3	Cefoperazone (Cefoperazone Sodium)FDA Link 07/2023 - 01/2021
3	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 01/2023 - 02/2019
3	Muscarinic AntagonistsIBA 12/2022 - 06/2018
3	Lapatinib (GW572016)FDA Link 10/2021 - 11/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
3	Interleukin-8 (Interleukin 8)IBA 01/2021 - 03/2010
2	CytokinesIBA 12/2023 - 03/2010
2	GoldIBA 01/2023 - 10/2021
2	Therapeutic UsesIBA 01/2023 - 05/2011
2	Peptides (Polypeptides)IBA 01/2022 - 01/2021
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 05/2018
2	Small Interfering RNA (siRNA)IBA 12/2021 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 11/2008
2	human ERBB2 proteinIBA 10/2021 - 11/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 03/2010
2	Tiotropium Bromide (Spiriva)FDA Link 09/2019 - 06/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2018 - 11/2015
2	Metalloproteases (Metalloproteinases)IBA 07/2016 - 02/2015
2	Estrogen ReceptorsIBA 02/2016 - 11/2013
2	Matrix Metalloproteinases (MMPs)IBA 04/2015 - 02/2015
2	Phosphotransferases (Kinase)IBA 05/2014 - 01/2013
2	tyrosine receptor (receptor, tyrosine)IBA 05/2014 - 01/2013
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2011 - 11/2010
1	dacomitinibIBA 02/2024
1	7-hydroxycoumarin (umbelliferone)IBA 06/2023
1	Colistin (Coly-Mycin)FDA Link 04/2023
1	Carbapenems (Carbapenem Antibiotics)IBA 04/2023
1	AntigensIBA 01/2023
1	PolymersIBA 01/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	RamucirumabIBA 01/2023
1	OligodeoxyribonucleotidesIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Decellularized Extracellular MatrixIBA 01/2023
1	Cytidine Monophosphate (CMP)IBA 11/2022

Therapy/Procedure

27	Therapeutics 01/2023 - 06/2005
5	Catheters 01/2012 - 08/2007
4	Drug Therapy (Chemotherapy) 09/2023 - 05/2018
3	Immunotherapy 01/2023 - 01/2023
3	Precision Medicine 01/2023 - 01/2019
3	Radiotherapy 01/2022 - 09/2020
2	Self Expandable Metallic Stents 09/2019 - 05/2018
2	Critical Care (Surgical Intensive Care) 04/2019 - 04/2008
2	Length of Stay 01/2012 - 11/2006
1	Oral Administration 06/2023
1	Neoadjuvant Therapy 01/2023